HK1251022A1 - 診斷方法 - Google Patents

診斷方法

Info

Publication number
HK1251022A1
HK1251022A1 HK18110418.3A HK18110418A HK1251022A1 HK 1251022 A1 HK1251022 A1 HK 1251022A1 HK 18110418 A HK18110418 A HK 18110418A HK 1251022 A1 HK1251022 A1 HK 1251022A1
Authority
HK
Hong Kong
Prior art keywords
diagnostic methods
diagnostic
methods
Prior art date
Application number
HK18110418.3A
Other languages
English (en)
Inventor
Sonya M Marshall-Gradisnik
Donald R Staines
Peter Kenneth Smith
Original Assignee
Univ Griffith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2015901567A external-priority patent/AU2015901567A0/en
Application filed by Univ Griffith filed Critical Univ Griffith
Publication of HK1251022A1 publication Critical patent/HK1251022A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK18110418.3A 2015-05-01 2018-08-14 診斷方法 HK1251022A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2015901567A AU2015901567A0 (en) 2015-05-01 Diagnostic Methods
AU2015904991A AU2015904991A0 (en) 2015-12-02 Diagnostic Methods
AU2016901468A AU2016901468A0 (en) 2016-04-20 Diagnostic Methods for Chronic Fatigue Syndrome and Myalgic Encephalomyelitis
PCT/AU2016/050313 WO2016176726A1 (en) 2015-05-01 2016-04-29 Diagnostic methods

Publications (1)

Publication Number Publication Date
HK1251022A1 true HK1251022A1 (zh) 2019-01-18

Family

ID=57217430

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18110418.3A HK1251022A1 (zh) 2015-05-01 2018-08-14 診斷方法

Country Status (6)

Country Link
US (1) US11773445B1 (zh)
EP (1) EP3289106A4 (zh)
AU (2) AU2016257772B2 (zh)
CA (1) CA3021399A1 (zh)
HK (1) HK1251022A1 (zh)
WO (1) WO2016176726A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11071730B2 (en) 2018-10-31 2021-07-27 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds
EP3873903B1 (en) 2018-10-31 2024-01-24 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds as hpk1 inhibitors
WO2020237025A1 (en) 2019-05-23 2020-11-26 Gilead Sciences, Inc. Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
CN110343759A (zh) * 2019-06-03 2019-10-18 张鹏 Trpv4的用途及其抑制剂的用途和药物筛选方法
US20230045621A1 (en) * 2019-12-23 2023-02-09 The Jackson Laboratory Methods and systems for diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) from immune markers
CN111265545B (zh) * 2020-02-18 2022-04-26 广州中医药大学(广州中医药研究院) 一种治疗肺肿瘤的组合物
CN114381517B (zh) * 2022-03-25 2022-06-07 中国人民解放军总医院 检测SNP rs12569857多态性在制备筛查高原肺水肿易感人群试剂盒中的应用
CN114965781A (zh) * 2022-05-31 2022-08-30 北京豪思生物科技股份有限公司 血清中五氟利多的lc-ms/ms测定方法
WO2024031145A1 (en) * 2022-08-10 2024-02-15 Griffith University Methods for detecting post covid-19 condition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5547835A (en) 1993-01-07 1996-08-20 Sequenom, Inc. DNA sequencing by mass spectrometry
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
US6054632A (en) 1996-11-15 2000-04-25 New York Blood Center, Inc. Method of making monoclonal antibodies using polymorphic transgenic animals
US6692909B1 (en) 1998-04-01 2004-02-17 Whitehead Institute For Biomedical Research Coding sequence polymorphisms in vascular pathology genes
US6703228B1 (en) 1998-09-25 2004-03-09 Massachusetts Institute Of Technology Methods and products related to genotyping and DNA analysis
US6670464B1 (en) 1998-11-17 2003-12-30 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
US6573049B1 (en) 1999-07-26 2003-06-03 Nuvelo, Inc. Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease
US6653079B2 (en) 2000-03-13 2003-11-25 Freshgene, Inc. Methods for detection of differences in nucleic acids
US6660476B2 (en) 2000-05-02 2003-12-09 City Of Hope Polymorphisms in the PNMT gene
US6632606B1 (en) 2000-06-12 2003-10-14 Aclara Biosciences, Inc. Methods for single nucleotide polymorphism detection
USH2220H1 (en) 2001-08-10 2008-07-01 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
US7888497B2 (en) 2003-08-13 2011-02-15 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof
GB2415555B (en) 2004-06-26 2008-05-28 Plus Design Ltd Signalling method
WO2008010082A2 (en) * 2006-07-12 2008-01-24 Progenika Biopharma S.A. Diagnostic method for fibromyalgia (fms) or chronic fatigue syndrome (cfs)
NZ590832A (en) * 2008-07-04 2013-01-25 Decode Genetics Ehf Genetic variants for schizophrenia risk assessment
SI2401400T1 (sl) * 2009-02-27 2016-05-31 Protea Biopharma N.V. Metode in sestavki za ocenjevanje kroničnih avtoimunskih bolezni
WO2010120746A1 (en) 2009-04-15 2010-10-21 Oregon Health And Science University Polymorphisms in human trpv4 and methods of use thereof

Also Published As

Publication number Publication date
WO2016176726A1 (en) 2016-11-10
US11773445B1 (en) 2023-10-03
AU2016257772B2 (en) 2022-06-02
EP3289106A4 (en) 2019-03-20
CA3021399A1 (en) 2016-11-10
EP3289106A1 (en) 2018-03-07
AU2016257772A1 (en) 2017-11-30
AU2022224759A1 (en) 2022-09-22

Similar Documents

Publication Publication Date Title
IL290309A (en) Representative diagnoses
HK1258539A1 (zh) 微瞬間分析
EP3288455C0 (en) DIAGNOSTIC METHODS
GB2538731B (en) Methods
HK1251022A1 (zh) 診斷方法
GB201518762D0 (en) Methods
GB201507827D0 (en) Diagnostic test
SG10201404895XA (en) Diagnosis
GB201508927D0 (en) Methods
HUE055021T2 (hu) Spirométer
GB201508860D0 (en) Diagnostic method
GB201515655D0 (en) Methods
GB201409851D0 (en) Diagnostic method
GB2556001B (en) Diagnostic kits
GB201615753D0 (en) Diagnostic method
GB201504297D0 (en) Diagnosis
GB201408875D0 (en) Diagnostic method
GB201418803D0 (en) Diagnostic Apparatus
EP3535421C0 (en) DIAGNOSTIC METHODS
GB201512609D0 (en) Methods
GB201516557D0 (en) Diagnosis
GB201521972D0 (en) Companion diagnostic
AU2015904991A0 (en) Diagnostic Methods
GB201521339D0 (en) Methods
GB201520804D0 (en) Diagnostic test